Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

BACKGROUND: Imatinib induces responses and disease stabilisations in non-resectable patients with aggressive fibromatosis (AF). The precise target of imatinib in AF and predictive factors for response to treatment are unknown. METHODS: We investigated factors potentially predictive of response to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufresne, A, Bertucci, F, Penel, N, Le Cesne, A, Bui, B, Tubiana-Hulin, M, Ray-Coquard, I, Cupissol, D, Chevreau, C, Perol, D, Goncalves, A, Jimenez, M, Bringuier, P P, Blay, J Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939782/
https://www.ncbi.nlm.nih.gov/pubmed/20664593
http://dx.doi.org/10.1038/sj.bjc.6605783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939782/
https://www.ncbi.nlm.nih.gov/pubmed/20664593
http://dx.doi.org/10.1038/sj.bjc.6605783

Ejemplares similares